A detailed history of Harbour Investments, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Harbour Investments, Inc. holds 18 shares of EMBC stock, worth $272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 25 28.0%
Holding current value
$272
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$11.46 - $16.56 $80 - $115
-7 Reduced 28.0%
18 $0
Q2 2024

Jul 26, 2024

BUY
$10.13 - $14.6 $10 - $14
1 Added 4.17%
25 $0
Q4 2023

Feb 16, 2024

SELL
$12.87 - $19.09 $2,290 - $3,398
-178 Reduced 88.12%
24 $0
Q3 2023

Nov 15, 2023

BUY
$15.0 - $22.17 $90 - $133
6 Added 3.06%
202 $3,000
Q1 2023

May 15, 2023

SELL
$23.07 - $32.77 $161 - $229
-7 Reduced 3.45%
196 $5,000
Q4 2022

Feb 15, 2023

SELL
$25.29 - $35.48 $809 - $1,135
-32 Reduced 13.62%
203 $5,000
Q2 2022

Aug 15, 2022

BUY
$24.78 - $33.36 $5,823 - $7,839
235 New
235 $6,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $876M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.